Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FD8D7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,291
Award facts
- Contract value 100% obligated
- $42,290.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,290.55 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. Dupixent is a specialty pharmaceutical product used to treat atopic dermatitis, asthma, and other allergic conditions, representing a critical medical supply for military and veteran healthcare systems supported by the Defense Logistics Agency.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor supplying a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The contractor's consistent award of competitively issued, non-set-aside delivery orders demonstrates its capability to meet federal procurement requirements for specialized medical commodities.
Quick answers
Who was awarded contract SPE2DB25FD8D7?
SPE2DB25FD8D7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FD8D7 worth?
The government has obligated $42,291 on SPE2DB25FD8D7.
Is contract SPE2DB25FD8D7 an order under another contract?
Yes. SPE2DB25FD8D7 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD8D7 competed?
The extent of competition for SPE2DB25FD8D7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award